Pharmacology of opioid receptor subtype
Pharmacology of opioid receptor subtype
批准号:
8039257
负责人:
GAVRIL W PASTERNAK
金额:
$44.89万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-06-01 至 2015-04-30
关键词:
Absence of pain sensationAdverse effectsAlternative SplicingAnalgesicsAreaBackBehaviorBehavioralBinding SitesBiological ModelsC-terminalClassificationClinicalCloningDrug InteractionsDrug usageGrantHumanHypoglycemiaIndividualInvestigationKnock-outLaboratoriesMapsMediatingMedicineMethadoneModelingMolecularMorphineMusMutant Strains MiceNeuronsOpiatesOpioidOpioid ReceptorPainPatientsPharmaceutical PreparationsPharmacologyPopulationRNA SplicingRattusRoleSystemVariantbasein vivoinsightknockout animalmu opioid receptorsnaloxonazinepublic health relevancereceptorresponse
中文摘要
描述(由申请人提供):阿片类药物在治疗疼痛方面具有独特的医学地位,尽管由于滥用的可能性,它们也存在问题。大多数临床使用的阿片类药物通过mu阿片受体起作用。然而,患者对单个药物的广泛反应以及mu阿片类药物之间不完全交叉耐受性的表现提出了这些药物如何通过单个mu受体起作用的问题。二十多年前的药理学研究表明,mu受体存在多个亚群,这一概念现在已被克隆的mu受体mor1的剪接变体在小鼠,大鼠和人类中的克隆所证实。了解这些受体变异在行为中的作用对于这些药物的最佳使用是重要的。在这个应用中,我们建议扩展正在进行的研究,将克隆的MOR-1变体与其体内功能联系起来。我们认为,mu类阿片在体内的作用反映了许多mu受体变异的作用总和,而mu药物之间的差异反映了它们对这些受体群体的不同功效。我们建议使用反义作图、敲除动物和传统的行为方法来检验这一假设。我们还将绘制这些模型中变异的免疫组织化学表达图谱。额外的研究将集中在局部机制阿片类药物的作用作为一个模型系统来检查这些变体在一个更明确的系统。最后,我们将扩展转运蛋白在阿片类药物耐受性中的作用。总之,这些研究应该提供关于mor1剪接变异体在阿片类药物作用中的作用的见解,并更好地理解这些药物的使用。
英文摘要
DESCRIPTION (provided by applicant): Opiates have a unique place in medicine in the treatment of pain, although they also have problems due to the potential of abuse. Most clinically used opioids act through mu opioid receptors. Yet, the wide range of responses among patients to individual drugs and the demonstration of incomplete cross tolerance among mu opioids has raised questions regarding how these drugs could all be acting through a single mu receptor. Pharmacological studies going back over twenty years have suggested the existence of multiple subpopulations of mu receptors, a concept that has now been confirmed with the cloning of splice variants of the cloned mu receptor MOR-1 in mice, rats and humans. Understanding the role of these receptor variants in behavior is important for the optimal use of these drugs. In this application we propose to extend ongoing studies correlating the cloned MOR-1 variants with their functions in vivo. We believe that the effects of mu opioids in vivo reflect the summation of actions from a number of mu receptor variants and that differences among the mu drugs reflects their differing efficacies for these receptor populations. We propose to examine this hypothesis using both antisense mapping, knockout animals and traditional behavioral approaches. We also will map the expression of the variants in these models immunohistochemically. Additional studies will focus on topical mechanisms of opioid action as a model system to examine these variants in a more defined system. Finally, we will expand upon the role of transporters in opioid tolerance. Together, these studies should provide insights into the role of the MOR-1 splice variants on opioid action and a better understanding of the use of these drugs.
PUBLIC HEALTH RELEVANCE: Morphine and related mu opiates produce their effects through a set of mu receptors, including both analgesia and most of their side-effects. These mu subtypes have been cloned and characterized at the molecular level. By understanding the functional roles of the various mu receptor subtypes, it may be come possible to develop analgesics lacking these side-effects, and possibly even reinforcing potential.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2116182
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:7478790
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2458335
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6378250
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:7106618
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2116181
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6655514
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:6925411
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6174506
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:6773089
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2116180
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2756682
-
项目类别:
-
资助金额:$9.72万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:2749018
-
项目类别:
-
资助金额:$9.99万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
OPIATE RECEPTOR PHARMACOLOGY
-
批准号:6523152
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Opiate Receptor Pharmacology
-
批准号:7269932
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1994
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:2119575
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:6378513
-
项目类别:
-
资助金额:$29.48万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:3213918
-
项目类别:
-
资助金额:$14.77万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
Pharmacology of opioid receptor subtypes
-
批准号:7229520
-
项目类别:
-
资助金额:$39.47万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES
-
批准号:6515455
-
项目类别:
-
资助金额:$30.37万
-
财政年份:1991
-
负责人:GAVRIL W PASTERNAK
-
依托单位:
海外基金